138 related articles for article (PubMed ID: 38001010)
1. Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer.
Barsky AR; George J; Wroe AJ; Mittauer KE; Kaiser A; Herrera R; Yu J; Gutierrez AN; Alvarez D; McCulloch J; Kasper ME; Mehta MP; Chuong MD
Med Dosim; 2024 Summer; 49(2):121-126. PubMed ID: 38001010
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.
Liu C; Bhangoo RS; Sio TT; Yu NY; Shan J; Chiang JS; Ding JX; Rule WG; Korte S; Lara P; Ding X; Bues M; Hu Y; DeWees T; Ashman JB; Liu W
J Appl Clin Med Phys; 2019 Jul; 20(7):15-27. PubMed ID: 31112371
[TBL] [Abstract][Full Text] [Related]
3. Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation : A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPY.
Baues C; Marnitz S; Engert A; Baus W; Jablonska K; Fogliata A; Vásquez-Torres A; Scorsetti M; Cozzi L
Radiat Oncol; 2018 Jul; 13(1):122. PubMed ID: 29970105
[TBL] [Abstract][Full Text] [Related]
4. Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer.
Kato T; Ono T; Narita Y; Komori S; Murakami M
Med Dosim; 2022 Autumn; 47(3):216-221. PubMed ID: 35346554
[TBL] [Abstract][Full Text] [Related]
5. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
6. Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients.
Franceschini D; Cozzi L; Fogliata A; Marini B; Di Cristina L; Dominici L; Spoto R; Franzese C; Navarria P; Comito T; Reggiori G; Tomatis S; Scorsetti M
Radiat Oncol; 2022 Aug; 17(1):150. PubMed ID: 36028862
[TBL] [Abstract][Full Text] [Related]
7. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric study for spine stereotactic body radiation therapy: magnetic resonance guided linear accelerator versus volumetric modulated arc therapy.
Yadav P; Musunuru HB; Witt JS; Bassetti M; Bayouth J; Baschnagel AM
Radiol Oncol; 2019 Sep; 53(3):362-368. PubMed ID: 31553704
[TBL] [Abstract][Full Text] [Related]
9. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
[TBL] [Abstract][Full Text] [Related]
10. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy.
Takaoka T; Tomita N; Mizuno T; Hashimoto S; Tsuchiya T; Tomida M; Yanagi T
Technol Cancer Res Treat; 2021; 20():15330338211060170. PubMed ID: 34806489
[No Abstract] [Full Text] [Related]
12. Comparative treatment planning study for mediastinal Hodgkin's lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy.
Edvardsson A; Kügele M; Alkner S; Enmark M; Nilsson J; Kristensen I; Kjellén E; Engelholm S; Ceberg S
Acta Oncol; 2019 Jan; 58(1):95-104. PubMed ID: 30280626
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
[TBL] [Abstract][Full Text] [Related]
14. Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy.
Rabe M; Palacios MA; van Sörnsen de Koste JR; Eze C; Hillbrand M; Belka C; Landry G; Senan S; Kurz C
Med Phys; 2023 May; 50(5):2625-2636. PubMed ID: 36810708
[TBL] [Abstract][Full Text] [Related]
15. Proton beam therapy can achieve lower vertebral bone marrow dose than photon beam therapy during chemoradiation therapy of esophageal cancer.
Zhang Y; Jabbour SK; Zhang A; Liu B; Yue NJ; Biswal NC
Med Dosim; 2021 Autumn; 46(3):229-235. PubMed ID: 33454170
[TBL] [Abstract][Full Text] [Related]
16. Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer.
Ferris MJ; Martin KS; Switchenko JM; Kayode OA; Wolf J; Dang Q; Press RH; Curran WJ; Higgins KA
Pract Radiat Oncol; 2019; 9(5):e473-e481. PubMed ID: 31077884
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
Welsh J; Gomez D; Palmer MB; Riley BA; Mayankkumar AV; Komaki R; Dong L; Zhu XR; Likhacheva A; Liao Z; Hofstetter WL; Ajani JA; Cox JD
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1336-42. PubMed ID: 21470796
[TBL] [Abstract][Full Text] [Related]
18. The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation.
Cozzi L; Comito T; Loi M; Fogliata A; Franzese C; Franceschini D; Clerici E; Reggiori G; Tomatis S; Scorsetti M
Technol Cancer Res Treat; 2020; 19():1533033820980412. PubMed ID: 33287650
[TBL] [Abstract][Full Text] [Related]
19. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
[TBL] [Abstract][Full Text] [Related]
20. Reduced lung dose during radiotherapy for thoracic esophageal carcinoma: VMAT combined with active breathing control for moderate DIBH.
Gong G; Wang R; Guo Y; Zhai D; Liu T; Lu J; Chen J; Liu C; Yin Y
Radiat Oncol; 2013 Dec; 8():291. PubMed ID: 24359800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
